Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

Share Price is delayed by 15 minutes
Get Live Data
2,060.00    19.00 (0.93%)
Bid:
2,059.00
Ask:
2,061.00
Spread: 2.00 (0.097%)
Market Cap: £44.80b
STAN Live PriceLast checked at - London Stock Exchange

Intraday Standard Chartered Share Chart

Total Voting Rights

13 May 2024 17:53

RNS Number : 2450O
Standard Chartered PLC
13 May 2024
 

STANDARD CHARTERED PLC

13 May 2024Voting Rights and Capital

The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1A.

Following the amendment of Standard Chartered PLC's Articles of Association, which took effect upon the passing of Annual General Meeting ("AGM") resolution 28 and the class meeting resolution on Friday 10 May 2024, on a poll each member is now entitled to one vote for every ordinary share held. Standard Chartered PLC also announced on Friday 10 May 2024 that it purchased 1,054,857 of its ordinary shares of US$0.50 each from J.P Morgan Securities plc, pursuant to the share buy-back programme previously detailed in the announcement of 26 February 2024.

As at close of business London time on 10 May 2024 and following the share buyback the same day, the issued share capital of Standard Chartered PLC consisted of:

2,583,474,266 ordinary shares of US$0.50 each with voting rights of one vote for every share held;

99,250,000 81/4 per cent non-cumulative irredeemable preference shares of £1 each with no equity voting rights;

96,035,000 73/8 per cent non-cumulative irredeemable preference shares of £1 each with no equity voting rights;

7,500 6.409 per cent non-cumulative redeemable preference shares of US$5 each with no equity voting rights;

7,500 7.014 per cent non-cumulative redeemable preference shares of US$5 each with no equity voting rights.

The total number of voting rights in Standard Chartered PLC as at close of business London time on 10 May 2024 was 2,583,474,266. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Standard Chartered PLC under the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rules. Any such notification should be sent to Investor.Relations@sc.com and Group-Corporate.Secretariat@sc.com.Standard Chartered PLC holds no shares in Treasury.

Contact name for Enquiries:

Rebecca Whibley, Group Corporate Secretariat

 

020 78859144

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRGPUGAAUPCGQW
Date   Source Headline
26th Oct 202312:20 pmRNSPublication of Supplementary Prospectus
26th Oct 20237:00 amRNS3rd Quarter Results
25th Oct 20236:05 pmRNSTransaction in Own Shares
24th Oct 20236:00 pmRNSTransaction in Own Shares
23rd Oct 20235:48 pmRNSTransaction in Own Shares
20th Oct 20235:55 pmRNSTransaction in Own Shares
19th Oct 20236:15 pmRNSTransaction in Own Shares
19th Oct 20232:30 pmRNSNotice of redemption
18th Oct 20236:05 pmRNSTransaction in Own Shares
17th Oct 20236:05 pmRNSTransaction in Own Shares
17th Oct 20232:23 pmRNSDirector/PDMR Shareholding
16th Oct 20236:26 pmRNSTransaction in Own Shares
13th Oct 20235:55 pmRNSTransaction in Own Shares
12th Oct 20236:05 pmRNSTransaction in Own Shares
11th Oct 20236:29 pmRNSTransaction in Own Shares
10th Oct 20236:20 pmRNSTransaction in Own Shares
9th Oct 20236:00 pmRNSTransaction in Own Shares
6th Oct 20236:00 pmRNSTransaction in Own Shares
5th Oct 20236:10 pmRNSTransaction in Own Shares
4th Oct 20236:15 pmRNSTransaction in Own Shares
3rd Oct 20236:13 pmRNSTransaction in Own Shares
2nd Oct 20236:30 pmRNSTransaction in Own Shares
2nd Oct 20233:40 pmRNSTotal Voting Rights
28th Sep 20236:27 pmRNSTransaction in Own Shares
27th Sep 20236:28 pmRNSTransaction in Own Shares
26th Sep 20236:21 pmRNSTransaction in Own Shares
25th Sep 20236:20 pmRNSTransaction in Own Shares
22nd Sep 20236:02 pmRNSTransaction in Own Shares
21st Sep 20236:00 pmRNSTransaction in Own Shares
20th Sep 20236:08 pmRNSTransaction in Own Shares
20th Sep 20234:10 pmRNSDirector/PDMR Shareholding
19th Sep 20236:20 pmRNSTransaction in Own Shares
19th Sep 20234:40 pmRNSOverseas Regulatory Announcement – Grant of awards
18th Sep 20236:10 pmRNSTransaction in Own Shares
18th Sep 20235:20 pmRNSDirector/PDMR Shareholding
15th Sep 20236:00 pmRNSTransaction in Own Shares
14th Sep 20236:10 pmRNSTransaction in Own Shares
13th Sep 20236:00 pmRNSTransaction in Own Shares
13th Sep 20234:50 pmRNSDirector/PDMR Shareholding
12th Sep 20236:05 pmRNSTransaction in Own Shares
12th Sep 202312:15 pmRNSDirector/PDMR Shareholding
11th Sep 20236:15 pmRNSTransaction in Own Shares
8th Sep 20236:09 pmRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
5th Sep 20236:10 pmRNSTransaction in Own Shares
4th Sep 20236:10 pmRNSTransaction in Own Shares
4th Sep 20231:50 pmRNSPublication of Supplementary Prospectus
1st Sep 20236:02 pmRNSTransaction in Own Shares
1st Sep 202312:05 pmRNSTotal Voting Rights
31st Aug 20236:13 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.